A Structural Atlas of Kinases Inhibited by Clinically Approved Drugs

Qi Wang(Tianjin University of Science and Technology), John Kuriyan(Vanderbilt University), Julie A. Zorn(QB3)

Methods in enzymology on CD-ROM/Methods in enzymology

January 1, 2014

10.1016/b978-0-12-397918-6.00002-1

Cited by 54

Related Papers

Crystallographic <i>R</i> Factor Refinement by Molecular Dynamics

|Science|1987|2k

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase

|Science|2000|1.8k

The Conformational Plasticity of Protein Kinases

|Cell|2002|1.8k

An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor Receptor

|Cell|2006|1.6k

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

|Cancer Cell|2002|1.6k